Arthritis Pain Reliever
NDC Package 33261-665-50
Package Information
Arthritis Pain Reliever is do not take more than directed (see overdose warning) adults take 2 caplets every 8 hours with water swallow whole - do not crush, chew, split or dissolve do not take more than 6 caplets in 24 hours do not use for more than 10 days unless directed by a doctor under 18 years of age ask a doctor. Marketed by Aidarex Pharmaceuticals Llc, this product is identified by NDC 33261-665 and is authorized under FDA application ANDA076200.
Identification & Billing
- RxCUI: 1148399 - acetaminophen 650 MG 8HR Extended Release Oral Tablet
- RxCUI: 1148399 - 8 HR acetaminophen 650 MG Extended Release Oral Tablet
- RxCUI: 1148399 - 8 HR APAP 650 MG Extended Release Oral Tablet
- RxCUI: 1148399 - acetaminophen 650 MG 8 HR Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 33261 - Aidarex Pharmaceuticals Llc
- 33261-665 - Arthritis Pain Reliever
- 33261-665-50 - 50 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
- 33261-665 - Arthritis Pain Reliever
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 33261-665-50 identifies a specific commercial package of 50 tablet, film coated, extended release in 1 bottle, plastic of Arthritis Pain Reliever, labeled by Aidarex Pharmaceuticals Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Aidarex Pharmaceuticals Llc on April 30, 2002. The current certification is valid through December 31, 2019.
How is this Aidarex Pharmaceuticals Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 33261066550. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.